In our study, patients in the 1st quartile subgroup of CF-PWV changes (i.e., with greatest CF-PWV reductions) were older, had longer diabetes duration and higher prevalence of arterial hypertension and, albeit they used more anti-hypertensive medications, they had higher BP levels and higher CF-PWV at the first measurement. This evidence concerns the gene CFTR and cystic fibrosis.